Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Total Valuation
Globus Medical has a market cap or net worth of $8.08B. The enterprise value is $7.31B.
Market Cap$8.08B
Enterprise Value$7.31B
Share Statistics
Globus Medical has 112,949,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding112,949,280
Owned by Insiders0.72%
Owned by Institutions36.25%
Financial Efficiency
Globus Medical’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 3.21%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.21%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee475.35K
Profits Per Employee19.43K
Employee Count5,300
Asset Turnover0.48
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of Globus Medical is 109.01. Globus Medical’s PEG ratio is 6.21.
PE Ratio109.01
PS Ratio0.00
PB Ratio1.83
Price to Fair Value2.69
Price to FCF18.65
Price to Operating Cash Flow14.66
PEG Ratio6.21
Income Statement
In the last 12 months, Globus Medical had revenue of 2.52B and earned 102.98M in profits. Earnings per share was 0.76.
Revenue2.52B
Gross Profit1.48B
Operating Income165.99M
Pretax Income120.72M
Net Income102.98M
EBITDA378.94M
Earnings Per Share (EPS)0.76
Cash Flow
In the last 12 months, operating cash flow was 520.64M and capital expenditures -115.43M, giving a free cash flow of 405.21M billion.
Operating Cash Flow520.64M
Free Cash Flow405.21M
Free Cash Flow per Share3.59
Dividends & Yields
Globus Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change-8.55%
50-Day Moving Average67.09
200-Day Moving Average75.92
Relative Strength Index (RSI)39.26
Average Volume (3m)1.74M
Important Dates
Globus Medical upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Globus Medical as a current ratio of 2.54, with Debt / Equity ratio of 12.86%
Current Ratio2.54
Quick Ratio1.77
Debt to Market Cap<0.01
Net Debt to EBITDA-0.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Globus Medical has paid 17.74M in taxes.
Income Tax17.74M
Effective Tax Rate0.15
Enterprise Valuation
Globus Medical EV to EBITDA ratio is 28.97, with an EV/FCF ratio of 27.09.
EV to Sales4.36
EV to EBITDA28.97
EV to Free Cash Flow27.09
EV to Operating Cash Flow21.09
Balance Sheet
Globus Medical has $890.06M in cash and marketable securities with $537.19M in debt, giving a net cash position of -$352.87M billion.
Cash & Marketable Securities$890.06M
Total Debt$537.19M
Net Cash-$352.87M
Net Cash Per Share-$3.12
Tangible Book Value Per Share$14.37
Margins
Gross margin is 55.35%, with operating margin of 6.59%, and net profit margin of 4.09%.
Gross Margin55.35%
Operating Margin6.59%
Pretax Margin4.79%
Net Profit Margin4.09%
EBITDA Margin15.04%
EBIT Margin8.72%
Analyst Forecast
The average price target for Globus Medical is $87.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$87.38
Price Target Upside46.73% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast32.26%
EPS Growth Forecast112.87%